Form 8-K - Current report:
SEC Accession No. 0001437749-25-001220
Filing Date
2025-01-15
Accepted
2025-01-15 17:16:06
Documents
27
Period of Report
2025-01-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K opk20250113_8k.htm   iXBRL 8-K 28602
2 EXHIBIT 99.1 ex_764946.htm EX-99.1 9792
7 ex99jpm01.jpg GRAPHIC 41470
8 ex99jpm02.jpg GRAPHIC 133899
9 ex99jpm03.jpg GRAPHIC 85004
10 ex99jpm04.jpg GRAPHIC 89704
11 ex99jpm05.jpg GRAPHIC 92558
12 ex99jpm06.jpg GRAPHIC 108921
13 ex99jpm07.jpg GRAPHIC 86041
14 ex99jpm08.jpg GRAPHIC 84333
15 ex99jpm09.jpg GRAPHIC 104957
16 ex99jpm10.jpg GRAPHIC 104031
17 ex99jpm11.jpg GRAPHIC 116932
18 ex99jpm12.jpg GRAPHIC 26996
  Complete submission text file 0001437749-25-001220.txt   1649377

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA opk-20250115.xsd EX-101.SCH 3401
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opk-20250115_def.xml EX-101.DEF 11421
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE opk-20250115_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opk-20250115_pre.xml EX-101.PRE 11581
29 EXTRACTED XBRL INSTANCE DOCUMENT opk20250113_8k_htm.xml XML 2816
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33528 | Film No.: 25533695
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)